Lisa J. Herrinton

11.2k citations
191 papers · 8.1k indexed · h-index 50

Lisa J. Herrinton

189 papers receiving 7.9k citations

Peers

Lisa J. Herrinton
Comparison fields: 5 of 159
  • Oncology 1.9k
  • Rheumatology 1.1k
  • Ophthalmology 628
  • Genetics 1.7k
  • Health, Toxicology and Mutagenesis 791
Replace David W. Kaufman with:
David W. Kaufman United States
Samuel Shapiro United States
Shin‐Wook Kang South Korea
Walter Ageno Italy
Elham Rahme Canada
Jérôme Rossert France
Francesco Locatelli Italy
Emmanuel J. Favaloro Australia
Menno V. Huisman Netherlands
Ted R. Mikuls United States
Lisa J. Herrinton relative to David W. Kaufman United States David W. Kaufman's profile →
Citations per field
00.5×3.4×
David W. Kaufman · 1×
Citations per year

Countries citing papers authored by Lisa J. Herrinton

Since Specialization
Citations

This map shows the geographic impact of Lisa J. Herrinton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa J. Herrinton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa J. Herrinton more than expected).

Fields of papers citing papers by Lisa J. Herrinton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa J. Herrinton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa J. Herrinton. The network helps show where Lisa J. Herrinton may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lisa J. Herrinton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lisa J. Herrinton Line = papers co-authored together Lisa J. Herrinton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20235
2 20234
3 20221
4 202114
5 202114
6 20216
7 201812
8 201712
9 201620
10 201598
11 2012166
12 201133
13 2011123
14 2010107
15 200980
16 200938
17 200725
18 200754
19 2007116
20 19964

About Lisa J. Herrinton

Lisa J. Herrinton is a scholar working on Oncology, Geriatrics and Gerontology and Ophthalmology, having authored 191 papers that have together received 8.1k indexed citations. Recurring topics across this work include Stoma care and complications (24 papers), Inflammatory Bowel Disease (19 papers), Colorectal Cancer Surgical Treatments (16 papers), Rheumatoid Arthritis Research and Therapies (16 papers), Microscopic Colitis (13 papers), Nutrition and Health in Aging (12 papers), Colorectal Cancer Screening and Detection (12 papers) and Cancer survivorship and care (11 papers). The work is most often cited by research in Oncology (1.9k citations), Rheumatology (1.1k citations) and Ophthalmology (628 citations). Lisa J. Herrinton has collaborated with scholars based in United States, China and Israel. Frequent co-authors include James D. Lewis, Liyan Liu, James E. Allison, Mark C. Hornbrook, Marcia Grant, Robert S. Krouse, Neal H. Shorstein, Kevin Winthrop, Jeffrey R. Curtis and Christopher S. Wendel. Their work appears in journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026